| Gramicidin |
Topical |
III |
Infected wounds and ulcers |
Polycyclic lantibiotic |
| Polymixin B |
Topical |
III |
Gram-negative bacteria |
Cyclic polypeptide |
| Polymixin E (Colistin) |
Intravenus |
III |
A. baumannii/Pneumonia |
Cyclic polypeptide |
| Daptomycin |
Intravenous |
III |
Skin infection/bacteremia |
Lipopeptide |
| LL-37 |
Topical |
II |
Leg ulcers |
Human cathelicidn |
| Melittin |
Intradermal |
I/II |
Inflammation |
Alpha-helical peptide |
| Pexiganan (MSI-78) |
Topical |
III |
Diabetic foot ulcers |
Alpha-helical peptide |
| Omiganan (MBI-226) |
Topical |
III |
Antisepsis/catheter infections |
Derivative of indolicidine |
| OP-145 |
Ear drops |
I/II |
Chronic middle ear infection |
Derivative of LL-37 |
| P113 (PAC-113) |
Mouth rinse |
II |
Oral candidiasis |
Fragment of histatin-5 |
| hLF1-11 |
Intravenous |
I/II |
Bacterial/fungal infections |
Fragment of human lactoferrin |
| DPK-060 |
Ear drops |
II |
Acute external otitis |
Derivative of kininogen |
| AP-214 |
Intravenous |
II |
Postsurgical organ failure |
Derivative of α-MSH |
| PMX-30063 |
Intravenous |
II |
Acute bacterial skin infection |
Defensin mimetic |
